Results 71 to 80 of about 15,817 (194)

Chronic hepatitis B and hematological malignancies

Клиническая онкогематология, 2013
The active usage of monoclonal antibodies in therapy for hematology malignancies made reactivation of hepatitis B virus (HBV) infection one of the major health problems. Monoclonal antibodies are also used in solid tumors, rheumatic, gastroenterological,
A. O. Buyeverov, P. O. Bogomolov
doaj   +1 more source

Prophylaxis and treatment of hepatitis B infection in the setting of liver transplantation [PDF]

, 2011
Without any treatment, the prognosis of hepatitis B in liver transplant recipients is very poor. So, antiviral prophylaxis is very important in patients with hepatitis B who undergo liver transplantation. Before liver transplantation, a suppression of
D'Avola, D. (Delia), Herrero, J.I. (José Ignacio)   +1 more
core   +1 more source

Tenofovir Alafenamide Fumarate Reduces Virological Replication in HBeAg‐Negative Patients With Normal Alanine Aminotransferase: A 48‐Week Randomised Controlled Trial

Journal of Viral Hepatitis, Volume 33, Issue 3, March 2026.
ABSTRACT The optimal strategy for chronic hepatitis B virus (HBV) infected patients with negative hepatitis B e‐antigen (HBeAg) and normal alanine aminotransferase (ALT) remains uncertain. This study aimed to evaluate the safety and efficacy of tenofovir alafenamide fumarate (TAF) treatment in this patient population.
Qiumin Luo, Wenxiong Xu, Yeqiong Zhang, Xiangyong Li, Jing Lai, Jianguo Li, Xingrong Zheng, Hong Deng, Lubiao Chen, Xiang Zhu, Chan Xie, Liang Peng   +11 more
wiley   +1 more source

Switching to Tenofovir Therapy Versus Continuation of Entecavir for Patients With Hepatitis B Virus Infection: A Systematic Review and Meta‐Analysis

JGH Open
Background Hepatitis B virus (HBV) infection causes liver disease, including hepatocellular carcinoma. Controlling viral activity is crucial to reducing complications.
Muhammad Shahzil, Ammad Javaid Chaudhary, Talha Kashif, Ali Akram Qureshi, Anza Muhammad, Faiza Khan, Muhammad Saad Faisal, Muhammad Ali Khaqan, Hassam Ali, Yara Dababneh, Dilip Moonka   +10 more
doaj   +1 more source

HBV-INFECTION DE NOVO AFTER ORTHOTOPIC LIVER TRANSPLANTATION: CLINICAL AND VIROLOGICAL CHARACTERISTICS, ASSESSMENT OF ANTIVIRUS THERAPY EFFECTIVENESS

Вестник трансплантологии и искусственных органов, 2012
We studied 11 cases of HBV-infection de novo in patients after orthotopic liver transplantation performed because of non-viral cirrhosis. Serum НBeAg, was revedled in all patients. In most cases clinical course of HBV-infection was benign. Treatment with
O. I. Malomuzh, E. V. Chekletsova, X. M. Кhizroyev, V. A. Pets, S. V. Fokin, V. A. Taranov, O. M. Tsirulniкova, S. V. Gautier   +7 more
doaj   +1 more source

All‐Cause Mortality in Persons With HIV‐HBV Co‐Infection Treated for HBV in Rwanda: A Population‐Based Cohort Study

Journal of Viral Hepatitis, Volume 33, Issue 3, March 2026.
ABSTRACT Chronic hepatitis B virus (HBV) infection increases the risk of cirrhosis, hepatocellular carcinoma and non‐liver complications. HIV co‐infection accelerates disease progression and increases mortality risk compared to HBV mono‐infection, but its impact among treated individuals is not well documented in Sub‐Saharan Africa.
Jean Damascene Makuza, Michael Law, Joseph Puyat, Alnoor Ramji, Dahn Jeong, Richard L. Morrow, Prince Asumadu Adu, Marie Paul Nisingizwe, Alpamys Issanov, Georgine Cua, Héctor Alexander Velásquez García, Charles Berabose, Albert Tuyishime, Naveed Zafar Janjua   +13 more
wiley   +1 more source

LIVER TRANSPLANTATION AND HBV INFECTION

Вестник трансплантологии и искусственных органов, 2009
The paper describes the modern approaches in treatment of hepatitis B virus (HBV)-infected patients who underwent liver transplantation. The patients with HBV liver cirrhosis and waiting for orthotopic liver transplantation (OLT) have to receive long ...
O. I. Andreytseva, A. V. Kozlova, V. E. Sutkin   +2 more
doaj   +1 more source

Novel Long‐Read Sequencing Method for Characterisation of Hepatitis B Transcripts Show High Expression of Chimeric HBV/Human RNA

Liver International, Volume 46, Issue 3, March 2026.
ABSTRACT Background Hepatitis B virus (HBV) genomes integrated into human DNA significantly contribute to surface antigen (HBsAg) production and may drive hepatocellular carcinoma (HCC). Long‐read sequencing methods like Nanopore offer advantages over short‐read next‐generation sequencing (NGS) by providing continuous reads of whole transcripts, but ...
Joakim Bedner Stenbäck, Johan Ringlander, Maria Andersson, Jakob Holm Dalsgaard Thomsen, Sanna Abrahamsson, Gustaf E. Rydell, Magnus Lindh   +6 more
wiley   +1 more source

Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management [PDF]

, 2018
Chronic hepatitis B (CHB) is a major global health problem affecting an estimated 350 million people with more than 786000 individuals dying annually due to complications, such as cirrhosis, liver failure and hepatocellular carcinoma (HCC).
Chauhan, Ranjit, Gadiparthi, Chiranjeevi, Lahiri, Nivedita, Lingala, Shilpa, Michalak, Tomasz I., Mohanty, Smruti R., Satapathy, Sanjaya K., Wu, Jian   +7 more
core   +1 more source

Indeterminate Phase/Grey Zone of Chronic Hepatitis B: Clinical Features, Outcomes and Molecular Insights

Liver International, Volume 46, Issue 3, March 2026.
ABSTRACT Chronic hepatitis B virus (HBV) infection remains a global public health challenge, with a high risk of complications such as cirrhosis, hepatocellular carcinoma (HCC) and death. As outlined in current international society guidelines, antiviral therapies are aimed at preventing progression of liver disease to life‐threatening complications ...
Maria Stella Franzè, Teresa Pollicino, Jean‐Michel Pawlotsky, Vincent Leroy, Giovanni Raimondo, Giuliana Amaddeo   +5 more
wiley   +1 more source